Journal
CURRENT OPINION IN MICROBIOLOGY
Volume 52, Issue -, Pages 84-89Publisher
CURRENT BIOLOGY LTD
DOI: 10.1016/j.mib.2019.05.008
Keywords
-
Categories
Funding
- UK NERC [NE/P001165/1]
- UK MRC [MR/R015600/1]
- MRC [MR/R015600/1] Funding Source: UKRI
- NERC [NE/P001165/1] Funding Source: UKRI
Ask authors/readers for more resources
The discovery in 2009 of a new species of yeast, Candida auris, heralded the arrival of a novel emerging human infectious disease. This review highlights the unique characteristics of C. auris that have lied to it being of public health concern worldwide, namely public health concern, namely its global emergence, its ability to cause nosocomial outbreaks in healthcare settings, its innate and emerging resistance to multiple antifungal drugs and its resilience in the face of hygiene and infection control measures. Genomic epidemiology has identified four emergences of C. auris marked by four clades of the pathogen. These clades of C. auris are genetically dissimilar and are associated with differential resistance to antifungal drugs, suggesting that they will continue to phenotypically diverge into the future. The global emergence of C. auris testifies to the unmapped nature of Kingdom Fungi, and represents a new nosocomial threat that will require enhanced infection control across diverse healthcare and community settings.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available